- Home
- CLSK vs BHVN Comparison
CLSK vs BHVN Comparison
Compare CLSK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLSK | BHVN |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 1.1B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | CLSK | BHVN |
|---|---|---|
| Price | $14.21 | $11.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 16 |
| Target Price | $23.83 | ★ $29.79 |
| AVG Volume (30 Days) | ★ 36.0M | 3.5M |
| Earning Date | 11-25-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $766,314,000.00 | N/A |
| Revenue This Year | $21.78 | N/A |
| Revenue Next Year | $17.55 | $2,219.74 |
| P/E Ratio | $12.53 | ★ N/A |
| Revenue Growth | ★ 102.21 | N/A |
| 52 Week Low | $6.45 | $7.48 |
| 52 Week High | $23.61 | $44.28 |
Technical Indicators
Market Signals| Indicator | CLSK | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 57.02 |
| Support Level | $13.57 | $8.29 |
| Resistance Level | $15.41 | $11.71 |
| Average True Range (ATR) | 1.29 | 0.72 |
| MACD | 0.31 | 0.47 |
| Stochastic Oscillator | 71.93 | 95.32 |
Price Performance
Historical ComparisonAbout CLSK CleanSpark Inc.
Cleanspark Inc. is a data center developer that, until recently, focused exclusively on bitcoin mining. The company provides scalable, energy-efficient digital infrastructure across the United States. The Company has a sole reporting segment, which is the bitcoin mining segment.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.